Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Translational Medicine
Published in: Journal of Translational Medicine 1/2014

Open Access 01-05-2014 | Oral presentation

Assessment of germline and somatic alterations in main candidate genes among patients with multiple primary melanoma

Authors: Maria Colombino, Maria Cristina Sini, Amelia Lissia, Antonio Cossu, Vincenzo De Giorgi, Daniela Massi, Ignazio Stanganelli, Corrado Rubino, Antonella Manca, Grazia Palomba, Gerardo Botti, Corrado Caracò, Nicola Mozzillo, Paolo Antonio Ascierto, Giuseppe Palmieri

Published in: Journal of Translational Medicine | Special Issue 1/2014

Login to get access

Excerpt

A series of patients with multiple primary melanoma (MPM) has been studied for assessing frequency and distribution of alterations in candidate genes involved in susceptibility (CDKN2A) and pathogenesis (BRAF, cKIT, CyclinD1) of such a disease. …
Metadata
Title
Assessment of germline and somatic alterations in main candidate genes among patients with multiple primary melanoma
Authors
Maria Colombino
Maria Cristina Sini
Amelia Lissia
Antonio Cossu
Vincenzo De Giorgi
Daniela Massi
Ignazio Stanganelli
Corrado Rubino
Antonella Manca
Grazia Palomba
Gerardo Botti
Corrado Caracò
Nicola Mozzillo
Paolo Antonio Ascierto
Giuseppe Palmieri
Publication date
01-05-2014
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue Special Issue 1/2014
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-12-S1-O3

Other articles of this Special Issue 1/2014

Journal of Translational Medicine 1/2014 Go to the issue

Poster presentation

Long-term response after electrochemotherapy in patients with relapsed or refractory cutaneous melanoma

Oral presentation

Ipilimumab treatment results in an early decrease in the frequency of circulating granulocytic myeloid derived suppressor cells as well as their arginase 1 production

Oral presentation

Harnessing host innate immunity may combat acquired resistance to BRAFi

Oral presentation

Systems biology analysis of immune signaling in peripheral blood mononuclear cells (PBMC) of melanoma patients receiving ipilimumab; basis for response biomarker identification

Poster presentation

A novel approach to target metastases of melanoma cells in an organ-selective manner

Poster presentation

Overall survival of patients with chemotherapy-naive advanced melanoma treated with ipilimumab 3 mg/kg in clinical trials
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits